Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis

Multiple Sclerosis

Volumn 22, Issue 2, 2016, Pages 245-249

  Fainardi, Enrico ^a   Bortolotti, Daria ^b   Bolzani, Silvia ^b   Castellazzi, Massimiliano ^b   Tamborino, Carmine ^b   Roversi, Gloria ^b   Baldi, Eleonora ^a   Caniatti, Maria Luisa ^a   Casetta, Ilaria ^b   Gentili, Valentina ^b   Granieri, Enrico ^b   Rizzo, Roberta ^b   Tola, M R ^c   Dallocchio, F ^c   Bellini, T ^c   Rotola, A ^c   Di Luca, D ^c   Seraceni, S ^c   Contini, C ^c   Sabbioni, S ^c   Negrini, M ^c   Tognon, M ^c   Antonelli, T ^c   Groppo, E ^c   Gentile, M ^c   Ceruti, S ^c   Manfrinato, M R ^c   Trentini, A ^c   Miotto, E ^c   Ferracin, M ^c   Mazzoni, E ^c   Pietrobon, S ^c   Masini, I ^c   Rotondo, J C ^c   Martini, F ^c   Baruzzi, A ^c   Roberto D'Alessandro, R ^c   Michelucci, R ^c   Salvi, F ^c   Stecchi, S ^c   Scandellari, C ^c   Terzano, G ^c   Granella, F ^c   Nichelli, P ^c   Sola, P ^c   Ferraro, D ^c   Vitetta, F ^c   Simone, A M ^c   Bedin, R ^c   Marcello, N ^c   Motti, L ^c   Montepietra, S ^c   Guidetti, D ^c   Immovilli, P ^c   Montanari, E ^c   Pesci, I ^c   Guareschi, A ^c   Greco, G ^c   Santangelo, M ^c   Mauro, A M ^c   Malagu S ^c   Rasi, F ^c   Spadoni, M ^c   Galeotti, M ^c   Fiorani, L ^c   Neri, W ^c   Ravasio, A ^c   Pasquinelli, M ^c   Gutman, S ^c   Monaldini, C ^c   more..

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c NONE

Author keywords

CSF levels; dimeric form; HLA G; MRI activity; Multiple Sclerosis

Indexed keywords

BIOLOGICAL MARKER; HLA G ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RADIODENSITOMETRY; SIGNAL PROCESSING; WESTERN BLOTTING; BRAIN; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DIMERIZATION; INFLAMMATION; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOLOGY; SPINAL CORD; AGED; BIOTINYLATION; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; IMMUNOPRECIPITATION; KOLMOGOROV SMIRNOV TEST; NEUROLOGIC EXAMINATION; YOUNG ADULT;

ADULT; BLOTTING, WESTERN; BRAIN; CASE-CONTROL STUDIES; DIMERIZATION; FEMALE; HLA-G ANTIGENS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; SPINAL CORD;

EID: 84957105441     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515590647     Document Type: Article

References (11)

1. Wiendl H, Feger U, Mittelbronn M, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: Implications for CNS immunity. Brain 2005; 128: 2689-2704.
2. Fainardi E, Rizzo R, Melchiorri L, et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: Relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 2003; 142: 149-158.
3. Fainardi E, Rizzo R, Melchiorri L, et al. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler 2006; 12: 2-12.
4. Fainardi E, Rizzo R, Melchiorri L, et al. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis. Mult Scler 2008; 14: 446-454.
5. Fainardi E, Rizzo R, Melchiorri L, et al. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007; 192: 219-225.
6. Shiroishi M, Kuroki K, Ose T, et al. Efficient leukocyte Ig-like receptor signalling and crystal structure of disulphide-linked HLA-G dimer. J Biol Chem 2006; 281: 10439-10447.
7. Apps R, Gardner L, Sharkey AM, et al. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37: 1924-1937.
8. Zilberman S, Schenowitz C, Agaugué S, et al. HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment. Eur J Immunol 2012; 42: 1599-1608.
9. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
10. Gonzalez A, Alegre E, Arroyo A, et al. Identification of circulating nonclassic Human Leukocyte Antigen G (HLA-G)-like molecules in exudates. Clin Chem 2011; 57: 1013-1022.
11. Teunissen C, Menge T, Altintas A, et al. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013; 19: 1802-1809.